DossierENTITY

Ozivy

Coverage of Ozivy in the Nexus archive.

Earliest in view: May 27 · 13:33 UTCMost recent: May 27 · 13:33 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 27 · 13:33 UTCSTAT NEWS
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
The FDA has extended the decision deadline for AstraZeneca's experimental breast cancer pill, camizestrant, to review additional data after an advisory panel raised concerns about a late-stage trial's design. Brazil approved the first generic version of Novo Nordisk's Ozempic (now Ozivy) by EMS, a pharmaceutical company, which plans to sell it at 30% lower cost.